Exomes were captured using
TruSeq Exome Enrichment kit or Agilent
SureSelectXT Human All Exon V4. Paired-end sequencing was performed using the Illumina
HiSeq2000 instrument.
CCNF exons were sequenced using Fluidigm Access Array target enrichment and the
MiSeq sequencing platform (Illumina). Amplicon primers were designed using the Fluidigim D3 Design Studio to produce 150 bp amplicons targeting the exons of
CCNF.
Validation and analysis of the
CCNF mutations was performed by direct DNA sequencing following PCR amplification of coding exons (NM_001761). PCR products were Sanger sequenced using Big-Dye terminator sequencing and an
ABI 3730XL DNA analyser (Applied Biosystems).
SNP genotyping in control individuals was performed using a custom
TaqMan SNP genotyping assay according to the manufacturer's instructions (Life Technologies) and analysed using a
Viia 7 real-time PCR system (Life Technologies).
Control exome data from 967 neurologically healthy individuals of predominantly Western European descent obtained from the Diamantina Institute, University of Queensland (Diamantina Australian Control Collection).
Williams K.L., Topp S., Yang S., Smith B., Fifita J.A., Warraich S.T., Zhang K.Y., Farrawell N., Vance C., Hu X., Chesi A., Leblond C.S., Lee A., Rayner S.L., Sundaramoorthy V., Dobson-Stone C., Molloy M.P., van Blitterswijk M., Dickson D.W., Petersen R.C., Graff-Radford N.R., Boeve B.F., Murray M.E., Pottier C., Don E., Winnick C., McCann E.P., Hogan A., Daoud H., Levert A., Dion P.A., Mitsui J., Ishiura H., Takahashi Y., Goto J., Kost J., Gellera C., Gkazi A.S., Miller J., Stockton J., Brooks W.S., Boundy K., Polak M., Muñoz-Blanco J.L., Esteban-Pérez J., Rábano A., Hardiman O., Morrison K.E., Ticozzi N., Silani V., de Belleroche J., Glass J.D., Kwok J.B., Guillemin G.J., Chung R.S., Tsuji S., Brown RH J.r., García-Redondo A., Rademakers R., Landers J.E., Gitler A.D., Rouleau G.A., Cole N.J., Yerbury J.J., Atkin J.D., Shaw C.E., Nicholson G.A, & Blair I.P. (2016). CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature Communications, 7, 11253.